OC-103

N/A

Report date: 2023/10/26 16:48:49

Base Information

Drug NameOC-103
Drug Alias NameOC-103
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsKeratoconjunctivitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOyster Point Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesOyster Point Pharma Inc
Inactive CompaniesN/A
Active IndicationsKeratoconjunctivitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A